NUF2 Is a Potential Immunological and Prognostic Marker for Non-Small-Cell Lung Cancer

Table 2

GO and KEGG pathway enrichment analyses of DEGs in the most significant module.

ID	Description	value	Count in gene set
GO:0000280	Nuclear division	2.12e-13	9
GO:0048285	Organelle fission	5.13e-13	9
GO:0140014	Mitotic nuclear division	6.78e-13	8
GO:0000075	Cell cycle checkpoint	1.95e-09	6
GO:0016572	Histone phosphorylation	7.14e-09	4
GO:0000793	Condensed chromosome	1.12e-13	8
GO:0098687	Chromosomal region	3.76e-10	7
GO:0000779	Condensed chromosome, centromeric region	5.40e-09	5
GO:0030496	Midbody	3.70e-08	5
GO:0000775	Chromosome, centromeric region	6.39e-08	5
GO:0035173	Histone kinase activity	2.87e-10	4
GO:0004674	Protein serine/threonine kinase activity	0.003	3
GO:0008022	Protein C-terminus binding	0.007	2
GO:0008199	Ferric iron binding	0.007	1
GO:0016725	Oxidoreductase activity, acting on CH or CH2 groups	0.009	1
hsa04115	p53 signaling pathway	2.11e-07	4
hsa04914	Progesterone-mediated oocyte maturation	6.22e-05	4
hsa04110	Cell cycle	1.18e-04	4
hsa04114	Oocyte meiosis	1.33e-04	4
hsa04218	Cellular senescence	2.34e-04	4

GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes; DEGs: differentially expressed genes; FDR: false discovery rate.